Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for pharmaceutical industry professionals · Tuesday, September 25, 2018 · 462,999,985 Articles · 3+ Million Readers

Ensuring Quality in pharmaceutical industries to Maintain public safety - OMICS Group Pharmaceutical Conferences

2nd International Summit on GMP, GCP & Quality Control 2013

Workshop on Zippy Lean Workshop by Lean compliance partners, USA

Workshop on Pharmacovigilance: Beyond GCP

2nd International Summit on GMP, GCP & Quality Control during November 12-14, 2013, DoubleTree by Hilton Hotel Chicago - North Shore Conference Center USA.

LOS ANGELES, CA, USA, July 26, 2013 /EINPresswire.com/ -- Good Manufacturing Practices (GMP)
Pharmaceutical companies must adhere to Good Manufacturing Practices (GMP) to ensure the quality of life of the people that consume it. GMP plays a crucial role in providing theruptuic solutions at an affordable cost.

A poor quality medicine may contain toxic waste that won’t produce any relief to the patient if administered for a particular problem. A poor quality medicine is not only harmful but also a waste of public and private money. Many countries of the world import only those medicines that follow internationally acceptable manufacturing practices.

Good Clinical Practice (GCP)
Good Clinical Practices are quality standards prescribed for the pharmaceutical companies that indulge in clinical Research and clinical trials. Protection of Human Rights and ensuring public safety are chief among them. ICH, an international body has already set the standards and regulations for clinical trials.

Quality Control
Quality control plays vital role in ensuring the appropriate combination of various compounds that ought to be present in the drugs, particularly the injectable ones that bypass the human immune system. Although stringent legislation and guidelines are framed for the drug manufacturers, several illegal practices are creeping in under the guise of compound companies that often exempt themselves from the legislator regulations.

OMICS Group GMP-2013 attains significance as it addresses all the issues related to GMP, GCP and quality control in the pharmaceutical industry. It brings a unique International mix of large and medium Pharmaceutical & Medical Devices companies, Business Entrepreneurs, Pharmaceutical Consultants, leading Universities and Research institutions together and creates a perfect platform to share experience, foster collaborations across industry and academia and evaluate emerging technologies in improving the manufacturing quality of product across the globe. The conference is an approach that extends beyond ordinary statistical quality control techniques and quality improvement methods. It implies a complete overview and re-evaluation of the specification of a product, rather than just considering a more limited set of changeable features within an existing product.

Prominent Speakers:
• Jennifer Lenÿ, Deputy Regional Director, American Society for Quality, USA
• Constance E Curts, FDA and EU Regulatory Validation Consultant, USA
• James Huang, Quality Assurance, USA
• Peter Odeh, Biomedical Laboratory Scientist,USA
• Brigitte von Rechenberg, University of Zurich, Switzerland

Major Tracks of the event include:

• Current Regulations and Quality Standards
• Current GMP Guidelines for Pharmaceuticals
• The role of "C" in cGMP
• Good Clinical Practice
• Good Laboratory Practices and Clinical Trials
• Quality Inspections and Auditing
• Quality Control, Quality Assurance and Validation
• Legal Requirements for Medical Devices
• Contract Manufacturing
• Computational Strategies in GMP/GCP
• Analytical Method Development and Validation for Therapeutic Proteins
• Microbiology, Food and Nutraceuticals
• Novel Methods of Purification by Downstream Processing
Workshop on Lean Compliance
• Xiodongfeng, California state University conducts a workshop on “Pharmacovigilance: Beyond GCP
• A 4-hour hands-on workshop designed to teach the basic LEAN Manufacturing concepts to a varied audience including executives, managers, and operators.
• The Workshop alternates classroom learning with a realistic factory simulation taking participants through several rounds starting from a traditional manufacturing environment and progressing to a Lean Enterprise environment all along simulating waste elimination and improved flow of customer's demand.
• Workshop starts with a traditionally chaotic work environment.
• "Lean in progress" using teamwork, reduced batch sizes, standardized work, quality at the source, point of use storage, and improved layout and
• "Full Lean" is implemented using flow, "Kanban", load balancing, and customer pull systems

Workshop on Pharmacovigilance
Xiaodongfeng of California State University conducts a workshop on ‘Pharmacovigilance: Beyond GCP

For more details on GMP-2013 conference, please visit:
http://www.omicsgroup.com/conferences/gmp-quality-control-validation-2013/

For further details contact
Victor Oliver
GMP-2013
Pharma Conferences
5716 Corsa Ave, Suite110
Westlake, Los Angeles
CA-91362-7354, USA
Office Ph: +1-888-843-8169
Toll No +1-800-216-6499(USA & Canada)
Email gmp2013@omicsgroup.us or gmp2013@omicsonline.net
http://www.omicsonline.org/contact.php

Victor Oliver
OMICS Group Incorporation
+1- 888-843-8169
email us here

Powered by EIN Presswire